Medical Ceramics Market to Surpass US$ 7,690.12 Mn by 2030 - Coherent Market Insights

Global Medical Ceramics Market, by Material (Bio-inert (Aluminum Oxide, Zirconia, Carbon), Bio-active (Hydroxyapatite (HAP), Glass and Bioglass, zirconia alumina composite), Bio-resorbable, and Piezo Ceramics), by Application (Surgical Implants, Dental Implants, Orthopedic Implants, and Others), Medical Tools and Devices, and Prosthetics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 4,795.13 Million in 2022 and is expected to exhibit a CAGR of 6.1% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Increasing incidences of bone cancers such as osteosarcoma, chondrosarcoma, and Ewing’s sarcoma, which require bone replacement or surgeries, is in turn expected to propel growth of the medical ceramics market. For instance, on January 12 2022, the American Cancer Society’s estimated about 3,910 new cases in the United States will be diagnosed with primary bone sarcoma, this included cancers in both children and adults. In the U. S. will be diagnosed with primary bone sarcoma. It was estimated that 2,100 deaths (1,180 men and boys and 920 women and girls) from this disease will occur in the U. S. this year.

Global Medical Ceramics Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, the COVID-19 pandemic had a negative impact on the global medical ceramics market, owing to shortage of raw material for manufacturing medical ceramics. The global spread of the novel coronavirus, also known as the COVID-19 pandemic, had a devastating impact on supply chains of raw material for medical ceramics. For instance, in October 2021, according to an article published by National Center for Biotechnology Information, COVID-19 pandemic had been recognized as a trigger for redefining supply chains at the global level, and had created an intense debate within the academic community and among policy-makers and practitioners. Global supply chain (GSC) of raw materials disruption started after the World Health Organization (WHO) declared the coronavirus disease outbreak to be a global health emergency at the end of January 2020. During the first half of 2020, the virus spread to almost all the countries in partial or total lockdown.

According to Institute of Supply Management (ISM), about 75% of the companies reported supply chain (SC) disruptions, 80% expected some kind of disruptions in the near future, 62% reported delays in receiving goods, and 53% of firms reported difficulties. It is estimated that among the 450 million persons working in Global supply chain (GSCs), many have faced reduced income or even job loss due to COVID‐19 (Kippenberg, 2020). Globally, organizations had been shut down shops, and suspended production. Some sectors like garment, mining, jewelry, and automobiles had been suffering as the employees in these sectors are among the most vulnerable and being affected by the pandemic. Hence due to lockdown and covid-19 pandemic there was shortage in   raw material availability.

Global Medical Ceramics Market: Key Developments

On March 21 2022, Bredent medical GmbH & Co.KG, a pharmaceutical and medical device company, based in Germany, launched its whiteSKY Tissue Line and Alveo Line zirconia dental implants. The new concave sulcus design of the whiteSKY Tissue Line provided more space for peri-implant soft tissue. This was particularly advantageous in narrow gaps and led to improved aesthetics of dental implants. The new whiteSKY Alveo Line had several of the same features like whiteSKY but had been designed to fill the cavity immediately after extraction and could be customized according to the tooth size, gap in the tooth.

Browse 27 Market Data Tables and 28 Figures spread through 170 Pages and in-depth TOC on “Global Medical Ceramics Market”-  Forecast to 2030, Global Medical Ceramics Market, by Material (Bio-inert (Aluminum Oxide, Zirconia, Carbon), Bio-active (Hydroxyapatite (HAP), Glass and Bioglass, zirconia alumina composite), Bio-resorbable, and Piezo Ceramics), by Application (Surgical Implants, Dental Implants, Orthopedic Implants, and Others), Medical Tools and Devices, and Prosthetics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights related to medical ceramics market, click the link below:

https://www.coherentmarketinsights.com/market-insight/medical-ceramics-market-1261

Moreover, increasing launches of new products is expected to drive the global medical ceramics market over the forecast period. For instance, in November 2019, James R. Glidewell, Dental Ceramics, Inc., based in the U.S., launched, new metal-free implant ZERAMEX XT. Glidewell Dental had launched a new two-piece ceramic, metal-free implant ZERAMEX XT at the recently held 2019 Glidewell Dental Symposium in the U.S. The ceramic implant ZERAMEX XT offers clinicians a metal-free alternative supporting natural, esthetics, expanding Glidewell Dental implant portfolio.

Key Takeaways of the Global Medical Ceramics Market:

• Global medical ceramics market is expected to exhibit a CAGR of 6.1% during the forecast period due to increasing product launches. For instance, in November 2018, Straumann, the company that develops, dental equipment and supplies manufacturing company, launched several new products, including a new two-piece ceramic implant and a mini-implant system at the 27th Annual Scientific Meeting of the European Association for Osseointegration. The Straumann PURE CI range is designed for highly esthetic tooth replacement, especially in the esthetic zone. Made from a high-performance ceramic with the color and translucence of natural tooth roots, the implants have a ZLA surface to provide highly predictable osseointegration. More than a million mini implants were placed in 2017 and their popularity is growing rapidly – not least because they can avoid bone grafting procedures that would otherwise be necessary to support wider implants.
• Based on materials, bio-inert ceramics segment held a dominant position in market in 2022, as these material implants have enhanced wear resistant and biocompatible properties. For instance, in April 2022, New (High-performance liquid chromatography) HPLC, (Mass Spectrometry) MS, and chromatography data systems (CDS) Introduced in 2021–2022. PATfix HPLC is designed for in-process monitoring in biopharmaceutical development and production (gene therapies and vaccines). It is based on a bio-inert ceramic gradient pump with flow rates of up to 10 mL/min coupled with a UV or fluorescence detector. It uses customized monolithic columns for product monitoring or purification. The use of Bio-inert ceramics gradient pump is made in manufacturing High performance liquid chromatography.
• Among regions, North America is estimated to account for the largest market share in the global medical ceramics market over the forecast period, owing to high usage of implantable medical devices. Furthermore, rise in number of osteoporotic fractures in the U.S. and presence of relatively large number of medical device manufacturers seems to propel the market growth of medical ceramics equipements. For instance, in November 2018, the National Osteoporosis Foundation (NOF), released an update to its prevalence data revealing that an estimated 10.2 million adults in the U.S. had osteoporosis and another 43.4 million had low bone mass. According to Statistical data provided by National Center for Biotechnology Information, 54 million U.S. adults, representing 50 percent of the U.S. adult population, are at risk of breaking a bone. Moreover, in January 2021, American Association of Clinical Endocrinologists (AACE) which gave guidelines for postmenopausal women, there was increase in cases of Osteoporosis by 76% in the U.S. and women were facing the Osteoporosis problem more after menopause which was rising the surgeries for spinal fusion and bone transplantation.
• Major players operating in the global medical ceramics market include CoorsTek Medical, H.C. Starck GmbH, Tosoh Corporation, Noritake Co., Ltd., 3M ESPE, Morgan Advanced Materials plc, Ceramtec, Pl Ceramic GmbH, Lithoz, and Kyocera Corporation